Pancreaticoduodenectomies with concurrent colectomies for pancreatic and colon cancer are feasible, but their morbidity and oncological benefits are controversial. This review examines the outcomes of this combined procedure and finds that it is a viable option for select patients with anticipated negative resection margins. However, caution must be exercised due to increased complication rates, including severe ones. Patients should be carefully selected and treated at high-volume centers with expertise in both surgeries. A multidisciplinary approach involving imaging and neoadjuvant therapies is crucial for optimizing outcomes.
Review by Dumitrascu T in J Clin Med